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Resting mitochondrial matrix Ca2+ is maintained
through a mitochondrial calcium uptake 1 (MICU1)-
established threshold inhibition of mitochondrial cal-
cium uniporter (MCU) activity. It is not known how
MICU1 interacts with MCU to establish this Ca2+
threshold for mitochondrial Ca2+ uptake and MCU
activity. Here, we show that MICU1 localizes to the
mitochondrial matrix side of the inner mitochondrial
membrane and MICU1/MCU binding is determined
by a MICU1 N-terminal polybasic domain and two
interacting coiled-coil domains of MCU. Further
investigation reveals that MICU1 forms homo-oligo-
mers, and this oligomerization is independent of
the polybasic region. However, the polybasic region
confers MICU1 oligomeric binding to MCU and con-
trols mitochondrial Ca2+ current (IMCU). Moreover,
MICU1 EF hands regulate MCU channel activity, but
do not determine MCU binding. Loss of MICU1 pro-
motes MCU activation leading to oxidative burden
and a halt to cell migration. These studies establish
a molecular mechanism for MICU1 control of MCU-
mediated mitochondrial Ca2+ accumulation, and
dysregulation of this mechanism probably enhances
vascular dysfunction.INTRODUCTION
Receptor-mediated cytosolic Ca2+ flooding is rapidly cleared
by endoplasmic reticulum refilling, plasma membrane efflux,
and mitochondrial Ca2+ uptake (Berridge et al., 2003; Soboloff
et al., 2012). In most eukaryotic nonexcitable and excitable cells,1576 Cell Reports 5, 1576–1588, December 26, 2013 ª2013 The Autcarriers, exchangers, and channels regulate mitochondrial Ca2+
uptake during the resting and active states (Drago et al., 2011;
Duchen et al., 2008; Nicholls, 2005; Rizzuto et al., 2012; Santo-
Domingo and Demaurex, 2010; Williams et al., 2013). Following
G-protein-coupled receptor or receptor-tyrosine-kinase-agonist
stimulation, the mitochondrial Ca2+ uniporter (MCU) channel
rapidly transports elevated cytosolic Ca2+ into the mitochondrial
matrix utilizing the highly negative mitochondrial membrane
potential (DJm) (Bernardi, 1999; Gunter et al., 1994; Kirichok
et al., 2004). Mitochondrial Ca2+ uptake stimulates bioenergetics
through activation of Ca2+-sensitive dehydrogenases and thus
modulates ATP synthesis (Babcock et al., 1997; Balaban,
2009; Denton and McCormack, 1980; Duchen et al., 2008; Haj-
no´czky et al., 1995; Hansford, 1994; McCormack et al., 1990).
Reciprocally, mitochondrial Ca2+ overload promotes physical
damage to mitochondria leading to bioenergetic crisis and cell
death (Orrenius et al., 2003; Szalai et al., 1999). Pathophysiolog-
ical dysregulation of mitochondrial Ca2+ uptake has been linked
to organ damage via chronic oxidative burden, autophagy, and
cellular dysfunction (Baines et al., 2005; Ca´rdenas et al., 2010;
Clapham, 2007; Joiner et al., 2012; Lemasters et al., 2009; Mal-
lilankaraman et al., 2012b).
Mitochondrial Ca2+ uptake has been functionally described for
decades, but only recently using integrative bioinformatics and
RNAi screening approaches, three components of theMCU com-
plex (mitochondrial calcium uptake 1 [MICU1], MCU, and MCU
regulator 1) were identified that together constitute the activity of
MCU (Baughman et al., 2011;DeStefani et al., 2011;Mallilankara-
manet al., 2012a, b;Perocchi et al., 2010). Although themitochon-
drial uniporter complex tightly regulates Ca2+ influx, themolecular
mechanisms of uniporter regulation are unclear. This unknown
regulatorymechanism stems from the observation thatmitochon-
drial Ca2+ influx exhibits a finite trigger proposed as a ‘‘set point’’
in 1978 (Nicholls, 1978, 2005). The set point is overcome and
the mitochondria begins Ca2+ uptake at cytosolic Ca2+ levels
exceeding 3 mM. The trigger was characterized as the functionhors
ofMCU-associatedproteinMICU1which isable tosuppressmito-
chondrial Ca2+ uptake up to the cytosolic levels3 mMCa2+ (Mal-
lilankaraman et al., 2012b). Thus far, MICU1 is the only known
protein that interacts with MCU to prevent mitochondrial Ca2+
uptake under resting conditions (Mallilankaraman et al., 2012b),
but the MICU1 localization and the binding domains of the
MICU1/MCU complex that establish the set point are unknown.
Here, we show that MICU1 interacts with MCU in the mito-
chondrial matrix and MICU1/MCU binding is determined by a
MICU1 N-terminal polybasic domain and two coiled-coil MCU
domains. MICU1 EF hands regulate MCU channel activity, but
not MICU1/MCU binding. Additionally, loss of MICU1 induces
MCU activity leading to vascular endothelial oxidative stress
and diminished endothelial cell migration.
RESULTS
Protein Flux Analysis Establishes MICU1 Is
Compartmentalized in the Mitochondrial Matrix
The MCU pore subunit is located in the inner mitochondrial
membrane (IMM), and thus its regulator, MICU1, must be pre-
sent either in the intermembrane space or the matrix side of
the mitochondrial inner membrane. To determine the suborga-
nellar localization of MICU1, we developed a dynamic protein
flux assay using confocal microscopy in which the outer mito-
chondrial membrane (OMM) or both the OMM and IMM of the
mitochondria were selectively permeabilized and release of
MICU1 was subsequently visualized from the mitochondrial
compartments. HeLa cells were cotransfected with expression
vector pairs encoding yellow fluorescent protein (YFP)-tagged
MICU1 and monomeric red fluorescent protein (mRFP)-tagged
mitochondrial targeting sequence of matrix-localized cyto-
chrome c oxidase subunit 8 (COX8) (Figure 1B) or mitochondrial
intermembrane space protein, GFP-tagged cytochrome c
(cyto c) cotransfected with mRFP-COX8 (Figure 1A). Combina-
tions of both cyto c/COX8 and MICU1/COX8 showed general
mitochondrial localization (Figures 1A and 1B). To visualize the
MICU1 compartmentalization, the plasma membrane was per-
meabilized using 0.002% digitonin (20 mg/ml) and permeabilized
cells were bathed in digitonin-free intracellular medium (ICM)
before exposure to mitochondrial permeabilizing agents.
The cyto c/COX8 cotransfected permeabilized cells were sub-
jected to mastoparan (20 mg/ml), a wasp venom peptide toxin
that induces OMM permeabilization (Kluck et al., 1999; Pfeiffer
et al., 1995). The release of intermembrane-space-resident pro-
teins due to mastoparan was visualized by confocal microscopy
in real time. OMM permeabilization by mastoparan rapidly
released cyto c, but not matrix-localized COX8 (Figures 1C
and 1E). Similarly, MICU1-YFP/COX8-mRFP permeabilized cells
were exposed to mastoparan. We found that mitochondrial
localized MICU1 and COX8 were not released from the mito-
chondrial intermembrane space (Figures 1D and 1F). We next
asked whether permeabilization of both the OMM and the IMM
promotes MICU1 release from the mitochondrial matrix. Per-
meabilized cells were exposed to a fungal peptide, alamethicin
(20 mg/ml), that induces large pores in both mitochondrial mem-
branes (Kluck et al., 1999). Permeabilization of both membranes
induced the release of COX8 from the matrix in addition to cyto cCell Refrom the intermembrane space (Figures 1G, 1I, and 1P). It has
been recently reported that MICU1 exists in the intermembrane
space (Csorda´s et al., 2013), but similar to COX8, MICU1 was
released only upon permeabilization of both the OMM and
IMM by alamethicin (Figures 1H, 1J, and 1P). The integral inner
membrane channel pore subunit MCUwas not released bymas-
toparan or alamethicin permeabilization (Figures 1K–1P). The
dynamic protein flux assay was complemented by western blot
analysis. As expected, cyto c was released by both mastoparan
and alamethicin and appeared in the cytosolic supernatant (Fig-
ure 1Q). MICU1 was only released by alamethicin, whereas inte-
gral membrane MCU was not released by either mastoparan or
alamethicin (Figure 1Q). A soluble mitochondrial matrix protein
heat shock protein 60 (HSP60) was used as a substitute for
COX8 (Figure 1Q). Further, we examined whether MCU and
MICU1 diffuse rapidly after photobleaching. Photobleaching of
MICU1, but not MCU, showed rapid fluorescence recovery after
photobleaching (FRAP). This result suggested that MICU1 is less
associated with the IMM than MCU (Figure 1R). These results
reveal that MICU1 is compartmentalized in the mitochondrial
matrix side of the IMM.
Mapping of MICU1- and MCU-Binding Regions Reveals
Conserved MICU1 Polybasic Motif Domains, but Not EF
Hand Domains, Are Essential for MCU Binding
Although MICU1 and MCU form a complex (Mallilankaraman
et al., 2012b; Perocchi et al., 2010), it is not known which regions
of MICU1 and MCU determine binding. To map the binding re-
gions of MICU1 and MCU, we generated five hemagglutinin
(HA)-tagged MICU1 truncation mutants (Figure 2A) and trans-
fected these into COS-7 cells stably expressing GFP-tagged
full-length MCU. The transfected cell lysates were subjected to
immunoprecipitation and western blot analysis. Immunoprecipi-
tation of GFP-tagged MCU pulled down all MICU1 truncation
mutants except deletion of amino acids 131–200 (MICU1-D2)
(Figure 2B). Intriguingly, the MICU1-D1 (deletion of amino acids
61–130) partially interacts with wild-type MCU (Figure 2B).
Although the effect of the MICU1-D2 deletion was profound,
lack of any interaction suggests a conformational deformity of
MICU1-D2 as a result of the truncation. In contrast, the partial
interaction of MICU1-D1 suggests that the protein is maintaining
an interacting tertiary structure that is recognized by MCU.
Therefore, we examined the MICU1-D1 amino acid sequence
for evolutionarily conserved interaction motifs and found a series
of positively charged lysine residues (amino acids [aa] 99–110)
(Figures S1A and S1B) which corresponds to the consensus
sequence of a polybasic region motif which is known as not
only an interaction motif but also as a membrane-anchoring
motif (Hancock et al., 1990; Heo et al., 2006; Papayannopoulos
et al., 2005; Williams, 2003). The polybasic N-terminal region
domain was mutated to polyglutamine (MICU1-DK) (Figure 2C),
and MICU1-DK reduced MCU interactions (Figure 2D); however,
MICU1-DK still localized to the mitochondria (Figures S1D and
S1E). The marked, but not complete, loss of interaction with
MCU suggests the MICU1 polybasic region motif is a determi-
nant of MICU1/MCU interaction. The profound loss of binding
in MICU1-D2 may be a consequence of the deleted region’s
proximity to an EF hand of MICU1. To determine if the EF handsports 5, 1576–1588, December 26, 2013 ª2013 The Authors 1577
Figure 1. Protein Flux Dynamics Illustrate MICU1 Is Localized in the Mitochondrial Matrix Compartment
(A) HeLa cells were cotransfected with cytochrome c-GFP and COX8A-mRFP (MTS) plasmid constructs.
(B) Similarly, HeLa cells were cotransfected with MICU1-YFP and COX8-mRFP (MTS).
(C and D) Plasma membranes of HeLa cells were briefly permeabilized with digitonin (0.002% w/v) containing intracellular medium for 7 min. Cells were treated
with mastoparan (20 mg/ml) to trigger outer mitochondrial membrane permeabilization. Protein flux dynamics were visualized using confocal microscopy. The
(legend continued on next page)
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are necessary for MCU binding, both EF hands were mutated
(Figure 2C). Although functionally important (Mallilankaraman
et al., 2012b; Perocchi et al., 2010), the EF hands of MICU1 did
not determine MCU binding (Figure 2D). This result also demon-
strates that althoughMICU1-DK has functional EF hands, it failed
to interact with MCU (Figure 2D). We next asked whether EF
hands’ Ca2+ binding domains may participate in MCU/MICU1
binding. We therefore tested whether Ca2+ determines MICU1/
MCU binding using MICU1 full-length and single and double
EF1 and EF2 mutants. Our coimmunoprecipitation data demon-
strated that MICU1/MCU binding is independent of [Ca2+]
(Figure 2E). Together, these results indicate that the polybasic
region, but not the EF hands of MICU1, are determinant of
MCU binding.
MCU Coiled-Coil Domains Are Determinants of MICU1
Binding
Next to map which regions of MCU bind MICU1, we created
three MCU truncation mutants stably expressing in COS-7 cells
that were lacking aa 150–220 (MCU-D1), aa 291–320 (MCU-D2),
or aa 321–351 (MCU-D3; Figure 3A). Then, these stable cells
were transfected with full-length MICU1-HA plasmid constructs.
The pull-down of full-length MICU1-HA was unable to immuno-
precipitate MCU-D1 and MCU-D3 suggesting that these regions
corresponding to MCU coiled-coil domains are essential for
MICU1 binding (Figures 3B and S1C). To validate the coimmuno-
precipitation data, we performed fluorescence resonance
energy transfer (FRET) acceptor photobleaching to determine
whether MCU-D1 and -D3 interact with MICU1. Coexpression
of mitochondrial marker COX8A-mRFP and MCU-GFP con-
structs revealed that MCU D1, D2, and D3 mutants did not alter
the mitochondrial targeting (Figure S2). Comparable protein ex-
pressions of wild-type, D1, D2, and D3 MCU-GFP were selected
for FRET analysis. Expectedly, MCU-GFP and MICU1-YFP
interact; however, neither MCU-GFP nor MICU1-YFP interact
with matrix-localized COX8A-RFP (Figures 3C–3E). Similar to
coimmunoprecipitation analysis, MCU wild-type and MCU-D2,
but not MCU-D1 and MCU-D3, interact with MICU1 (Figures
3C and 3F–3H). Further, we have also conducted interaction
studies by yeast two-hybrid assay (Figure 3I). In support of coim-
munoprecipitation and FRET, MCU wild-type and MCU-D2
showed positive blue colonies, but MCU-D1 and MCU-D3 did
not, indicating that MCU wild-type and MCU-D2 interact withdepletion of either cyto c-GFP or MICU1-YFP was depicted as representative g
mRFP was depicted as representative red histogram lines from the same individu
and after (bottom three rows) mastoparan challenge (indicated by blue arrow). n
(E) Representative protein release traces from (C) of cytochrome c (green) and C
(F) Representative protein release traces from (D) of MICU1 (green) and COX8A
(G and H) Release illustration of cytochrome c and COX8A or MICU1 and COX
(20 mg/ml) addition (indicated by blue arrow). n = 6–9.
(I and J) Representative traces from (G) and (H) of cytochrome c and COX8A or
(K–O) Similar to cytochrome c and MICU1, MCU-GFP flux assessment was perf
(P) Dissipation of fluorescence intensity was calculated as flux rate after mastop
(Q) To assess the localization of MICU1, HeLa cells were permeabilized and expo
and mitochondrial (pellet) fractions were subjected to immunoblotting to examin
marker), MICU1-Flag, and MCU-GFP from mitochondria. Lanes 1, 2, and 3 refer
(R) Time course of FRAP from cells expressingMICU1-YFP or MCU-GFP. The FRA
Mean ± SEM; n = 6.
Cell ReMICU1 (Figure 3J). Collectively, these results demonstrate that
MCU-D1 and MCU-D3, regions corresponding to the coiled-
coil domains, are necessary for interaction with MICU1.
MICU1 Polybasic Region and EF Hands Regulate MCU-
Mediated Mitochondrial Ca2+ Uptake
We next sought to characterize whether MICU1 undergoes
oligomerization as a mechanistic step in regulation of MCU-
mediated Ca2+ uptake. To evaluate the possibility of MICU1 olig-
omerization, we developed a coimmunoprecipitation strategy
using cotransfection of two MICU1 constructs (MICU1-HA and
MICU1-Flag) in COS-7 cells. Coimmunoprecipitation of MICU1-
Flag with HA antibody indicated that MICU1-HA and MICU1-
Flag are able to form oligomeric complexes (Figure 4A, right
panel). Similarly, COS-7 cells were cotransfected with MICU1-
Flag and MICU1-DK-YFP plasmid constructs. Coimmunopre-
cipitation of MICU1-Flag with GFP antibody indicated that
MICU1-Flag is still able to oligomerizewithMICU1-DK (Figure 4B,
right panel). These results demonstrate that the polybasic region
of MICU1 is not a MICU1/MICU1 interaction domain but instead
supports the polybasic region’s role in MCU interaction.
Having determined the binding regions of MCU and MICU1
through a series of deletion andmutation analysis, we next asked
whether MICU1-DK and MICU1-DEF1DEF2 affect MCU-medi-
ated [Ca2+]m uptake. Permeabilized control, MICU1-DK, and
MICU1-DEF1DEF2-expressing HeLa cells were loaded with
Fura-FF to determine [Ca2+]m uptake rate as a decay of extrami-
tochondrial Ca2+ and JC-1 to simultaneously monitor mito-
chondrial membrane potential (DJm) dynamics. MICU1 actively
inhibits MCU at cytosolic Ca2+ levels <3 mM (Mallilankaraman
et al., 2012b). Therefore, to determine the phenotype of the
MICU1-DK, HeLa cells were challenged with a 1 mM Ca2+ bolus,
well within the functional inhibitory range of wild-typeMICU1.We
found that MICU1-DK cells rapidly cleared the 1 mM Ca2+ bolus
under normal DJm indicating the loss of MICU1 inhibition of
MCU activity at <3 mM. Conversely, control cells did not exhibit
MCU-dependent Ca2+ uptake (Figures 4C–4F), because the
MICU1 inhibition was intact. Next, we examined the total amount
of Ca2+ buffered by control and MICU1-DK mitochondria using
the mitochondrial uncoupler, CCCP. MICU1-DK-overexpressing
cells accumulated large amounts of Ca2+ (Figure 4G) suggesting
that MICU1-DK is unable to properly interact with MCU to estab-
lish the set point for MCU-mediated Ca2+ uptake. Functionally,reen histogram lines from an individual experiment. The depletion of COX8A-
al experiment. Each row corresponds to different time intervals before (top row)
= 6–9. f.a.u., fluorescence arbitrary units.
OX8A (red) following mastoparan. n = 6–9.
(red) following mastoparan. n = 6–9.
8A flux dynamics before (top row) and after (bottom three rows) alamethicin
MICU1 and COX8A depletion before and after alamethicin addition. n = 6–9.
ormed. n = 6–9.
aran or alamethicin addition. Mean ± SEM; n = 6–9.
sed to mastoparan or alamethicin (20 mg/ml) for 5 min. Cytosolic (supernatant)
e the release of cytochrome c (intermembrane space marker), HSP60 (matrix
to triplicate samples. n = 3.
P recovery curve is a plot of the normalized fluorescence recovery versus time.






Figure 2. Mapping the MICU1 Interaction Domains with MCU
(A) Scheme depicts full-length MICU1 and truncation constructs.
(B) Stably MCU-GFP-expressing COS-7 cells were transfected with HA-tagged full-length MICU1 or truncations. Following immunoprecipitation with GFP
antibody, total cell lysates and immunoprecipitated materials were subjected to western blot analysis. Cell lysates were probed with HA (top left) or GFP (bottom
left) antibodies to serve as inputs. Immunoprecipitated samples were probed with HA (top right) or GFP (bottom right) antibodies. GFP antibodies coimmuno-
precipitate full-length MICU1, D3, D4, and D5 MICU1-HA truncations, but not MICU1-D1 and MICU1-D2. n = 3–5. IP, immunoprecipitation; WB, western blot.
(C) Scheme depicts full-length MICU1 and MICU1-DEF1, MICU1-DEF2, MICU1-DEF1DEF2, and MICU1-DK mutant constructs. WT, wild-type.
(D) Stably MCU-GFP-expressing COS-7 cells were transfected with Flag-tagged full-length MICU1 and mutants. Following immunoprecipitation with GFP
antibody, total cell lysates and immunoprecipitatedmaterials were subjected to western blot analysis. Cell lysates were probed with Flag (top left) or GFP (bottom
left) antibodies to serve as inputs. Immunoprecipitated samples were probed with Flag (top right) or GFP (bottom right) antibodies. GFP antibodies coimmu-
noprecipitate full-length MICU1, MICU1-DEF1, MICU1-DEF2, and MICU1-DEF1DEF2, but not MICU1-DK mutant. n = 3.
(E) As described in (D), stably MCU-GFP-expressing COS-7 cells were transfected with Flag-tagged MICU1-DEF1, MICU1-DEF2, and MICU1-DEF1DEF2
mutants. Cell lysates were incubated with or without 50 mM Ca2+, immunoprecipitation was performed with GFP antibody, and cell lysates were subjected to
western blot analysis. Cell lysates were probed with Flag (top left) or GFP (bottom left) antibodies to serve as inputs. Immunoprecipitated samples were probed
with Flag (top middle and right) or GFP antibodies (bottom middle and right).
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Figure 3. MCU Coiled-Coil Domains Are Determinant of MICU1 Binding
(A) Scheme depicts full-length MCU and truncation constructs.
(B) Stably MICU1-HA expressing COS-7 cells were transfected with GFP-tagged full-length MCU or truncations. Following immunoprecipitation with HA anti-
body, total cell lysates and immunoprecipitated materials were subjected to western blot analysis. Ten percent of cell lysates were probed with GFP (top left) or
HA antibodies (bottom left) to serve as inputs. Immunoprecipitated samples were probed with GFP (top right) or HA antibodies (bottom right). HA antibodies
coimmunoprecipitate full-length MCU and MCU-D2, but not MCU-D1 and MCU-D3. n = 3.
(C) HeLa cells were cotransfected with MCU-GFP donor and MICU1-YFP acceptor. MICU1-YFP acceptor was bleached, and a representative trace of the MCU-
GFP donor fluorescence is shown. n = 4.
(D) Similarly, MCU-GFP donor and COX8A-RFP acceptor. n = 4.
(E) MICU1-YFP donor and COX8A-RFP acceptor. n = 4.
(F) MCUD1-GFP donor and MICU1-YFP acceptor. n = 3.
(G) MCUD2-GFP donor and MICU1-YFP acceptor. n = 3.
(H) MCUD3-GFP donor and MICU1-YFP acceptor. n = 3.
(I) Scheme depicts yeast two-hybrid system for analysis of MCU and MICU1 binding.
(J) Full-length MCU; MCU-D1, MCU-D2, or MCU-D3; and MICU1 were subcloned into pGBKT7 and pGADT7 vectors as bait and prey, respectively. After
transformation, screening was performed by stringent selection (growth on quadruple dropout medium and resistance to the antibiotic aureobasidin A) and blue
colonies confirmed the MICU1/MCU interaction. Each column represents triplicates of MICU1/MCU, MICU1/MCU-D1, MICU1/MCU-D2, MICU1/MCU-D3,
MICU1/empty vector, and a positive control from the manufacturer (from left to right). n = 3.MICU1 EF hands are the Ca2+ sensor of the MCU complex, and
although EF hand mutants bind MCU (Figure 2D), the mutations
of EF1, EF2, or EF1/EF2 (Figure 2C) led to dysfunction with a
functional phenotype similar to MICU1 knockdown (KD) (Malli-Cell Relankaraman et al., 2012b) in which the mitochondria constitu-
tively accumulate Ca2+ that would otherwise remain as cytosolic
Ca2+ (Figures 4H–4L). These data indicate that both polybasic
and EF hands are essential for MICU1 regulation of MCU.ports 5, 1576–1588, December 26, 2013 ª2013 The Authors 1581
Figure 4. MICU1 Binding and Functional Domains Regulate MCU-Mediated Ca2+ Uptake
(A) COS-7 wild-type cells were cotransfected with HA-tagged full-length MICU1 and Flag-tagged full-length MICU1 plasmid constructs. Following immuno-
precipitationwith HA antibody, total cell lysates and immunoprecipitatedmaterials were subjected to western blot analysis. Cell lysates were probedwith HA (left)
or Flag antibodies (right panel, first three lanes) to serve as inputs. Immunoprecipitated samples were probed with Flag (right panel, last three lanes). n = 3.
(B) COS-7 wild-type cells were cotransfected with Flag-tagged full-length MICU1 and YFP-tagged MICU1-DK plasmid constructs. Following immunoprecipi-
tation with GFP antibody, total cell lysates and immunoprecipitated materials were subjected to western blot analysis. Cell lysates were probed with GFP (left) or
Flag (right panel, first three lanes) antibodies to serve as inputs. Immunoprecipitated samples were probed with anti-Flag (right panel, last three lanes). n = 3.
(C and D) HeLa cells were transfected with MICU1-DK plasmid, and stable cells were generated after G418 selection. MICU1-DK and wild-type cells were
permeabilized with 0.004% digitonin in ICM buffer and loaded with extramitochondrial ratiometric Ca2+ indicator Fura-2FF. These cells were also loaded with
ratiometric DJm indicator JC-1. Cells were then challenged with 1 mMCa
2+ bolus. Finally, total mitochondrial Ca2+ uptake and DJm dissipation were determined
by uncoupler CCCP. Mean ± SEM; n = 3–6.
(E) Quantitation of wild-type and MICU1-DK extramitochondrial [Ca2+]out (to 450 s). Mean ± SEM; **p < 0.01; n = 3–6.
(F) Quantitation of 1 mM Ca2+ bolus uptake, [Ca2+]m. Mean ± SEM; ***p < 0.001, n = 3–6.
(G) Quantitation of mitochondrial Ca2+ release following CCCP. Mean ± SEM; **p < 0.01, n = 3–6.
(H–L) Similar to MICU1-DK, EF hand double-mutant DEF1DEF2 was assessed for MCU-mediated Ca2+ uptake and DJm dynamics. Mean ± SEM; **p < 0.01,
***p < 0.001, n = 3–6.MICU1 Polybasic and EF Hand Motifs Regulate IMCU
Because MCU-mediated mitochondrial Ca2+ uptake is regu-
lated by MICU1, we examined whether MICU1-DK or MICU1-
DEF1DEF2 mutants were able to regulate MCU current (IMCU)1582 Cell Reports 5, 1576–1588, December 26, 2013 ª2013 The Autin HeLa cells. To measure IMCU, we utilized mitoplast patch-
clamp (Chaudhuri et al., 2013; Fieni et al., 2012; Joiner et al.,
2012; Kirichok et al., 2004). As a first step, freshly isolated mito-
chondria were loaded with DJm indicator, rhodamine 123, andhors
Figure 5. MICU1 Polybasic and EF Hand
Domains Regulate IMCU
(A) Mitoplasts generated from HeLa mitochondria
were loaded with DJm indicator rhodamine 123
and visualized using confocal microscopy (inset).
Mitoplast current (IMCU) was recorded before and
after application of 2 (red) or 100mM (black)Ca2+ to
thebathmedium.Currentsweremeasuredduring a
voltage ramp as indicated. IMCU recorded in the
presence of 2 mM Ca2+ was nearly completely in-
hibited by 50 nMof Ru360 (green trace). Traces are
a representative single recording of IMCU. n = 6.
(B) Mitoplasts generated from HeLa wild-type
cells (red), stable MICU1 KD (green), or stable
MCU KD (blue) were used for IMCUmeasurements.
IMCU was measured using 5 mM bath Ca
2+ unless
otherwise indicated. Nominal Ca2+-free buffer (no
EGTA; contaminant Ca2+ 6 mM) was used as a
control and trace shown in black. Traces are a
representative single recording of IMCU. n = 6–12.
(C) Similarly, IMCU from MICU1 mutants MICU1-
DEF1DEF2 (purple) and MICU1-DK (brown) mito-
plasts were measured and compared to wild-type
(red) and MICU1 KD (green). IMCU was measured
with 5 mM bath Ca2+ except for nominal Ca2+-free
(black) medium. Traces are a representative single
recording of IMCU. n = 6–12.
(D) IMCU densities (pA/pF) for wild-type (red),
MICU1KD (green), MCU KD (blue), MICU1-
DEF1DEF2 (purple), and MICU1-DK (brown).
Mean ± SEM; *p < 0.05; ns, not significant,
n = 6–12.the mitoplast preparation was confirmed by confocal imaging
(Figure 5A, inset). In the patch-clamp of whole-mitoplast config-
uration, the addition of 2mMCa2+ to the bath elicited an inwardly
rectifying Ca2+ current that is almost completely blocked by
50 nM Ru360 (Kirichok et al., 2004; Figure 5A). Next, we exam-
ined if knockdown of human MICU1 or MCU proteins altered
IMCU. Compared to control conditions, IMCU in mitoplasts from
MCUknockdown (MCUKD) cells was significantly lower (Figures
5B and 5D) which is correlated with MCU-mediated Ca2+ uptake
(Figures S3A–S3C). In sharp contrast, stable knockdown of
MICU1 exhibited larger IMCU (Figures 5B and 5D). Finally, we
conducted mitoplast patch-clamp recordings in MICU1-DK
and MICU1-DEF1DEF2 mutants overexpressing HeLa cells.
The electrophysiology revealed that MICU1-DK and DEF1DEF2
mitoplasts exhibited larger MCU current densities when
compared to MCU currents from wild-type (Figures 5C and
5D). Having demonstrated the MCU D1 and D3 role in MICU1
binding, we next tested whether deletion of coiled-coil domains
alter IMCU. MCU number 861 small hairpin RNA (shRNA)-insensi-
tive MCU full-length and mutant constructs were stably ex-
pressed in MCUKDHeLa cells, and IMCU wasmeasured (Figures
S3D–S3F). Reconstitution of full-length MCU in MCU KD mito-
plasts re-established IMCU (Figures S3E and S3F). Interestingly,
MCU-D1 and MCU-D3 generated larger IMCU than MCU-D2 indi-
cating that MCU-D1 and -D3 regions are necessary for MICU1-
mediated regulation of MCU activity. Taken together, these
data strongly support that loss of MICU1 polybasic or EF hands
increase the IMCU, exhibiting dominant negative phenotypes.Cell ReLoss of MICU1 Promotes Mitochondrial Ca2+
Accumulation andOxidative Burden, Halting Endothelial
Cell Migration
The ability of MICU1 to suppress MCU-mediated basal mito-
chondrial Ca2+ accumulation suggests that MICU1, rather than
the MCU pore, is sensing Ca2+ uptake from the cytosol (Mallilan-
karaman et al., 2012b). Ablation of MICU1 causes mitochondrial
Ca2+-dependent chronic oxidant elevation and cellular stress.
The MICU1 and MCU expression profiles in cell lines and pri-
mary cells indicated that human aortic endothelial cells have
relatively high levels of MICU1 mRNA when compared to other
cell types (Figures S4A and S4B; Aichberger et al., 2005). Never-
theless, MCU mRNA levels were relatively unchanged (Figures
S4A and S4B). Therefore, we tested whether MICU1 downregu-
lation impacts pathophysiological endothelial cell (EC) function.
Because EC function is compromised in various cardiovascular
disease states (Libby et al., 2006), we performed quantitative
RT-PCR (qRT-PCR) to assess MICU1 expression in human
control and cardiovascular disease (CVD)-derived primary ECs
(Table S1). MICU1, but not MCU, mRNA levels were markedly
downregulated in CVD ECs (Figure 6A). Basal [Ca2+]m was
considerably elevated in ECs derived from CVD patients when
compared to control ECs. Further, reconstitution of MICU1 in
CVD ECs reduced the [Ca2+]m accumulation (Figures 6B and
6C). These results were further confirmed by the reduction of
MICU1 protein in patients (Figure 6D). To examine if loss of
MICU1 led to more MCU activity, mitochondria were isolated
and mitoplast patch-clamp was performed. CVD ECs exhibitedports 5, 1576–1588, December 26, 2013 ª2013 The Authors 1583
Figure 6. Loss of MICU1 Exacerbates MCU-Mediated Ca2+ Uptake and Limits Endothelial Cell Migration
(A) Human peripheral veins were obtained from control and coronary/peripheral artery disease subjects (CAD/PAD). Freshly isolated ECs were cultured, and total
RNA was used for detection of MICU1 and MCU mRNA expression levels by qRT-PCR. Mean ± SEM; *p < 0.05; ns, not significant, n = 3–15.
(B and C) Confocal imaging and quantitation of basal [Ca2+]m accumulation as indicated bymitochondrial rhod-2 fluorescence in control, CVD, and CVD +MICU1
rescue ECs. Mean ± SEM; ***p < 0.001; n = 2–19 subjects.
(D) MICU1 protein expression in control and CVD ECs.
(E) IMCU is larger in human-CVD-endothelial-cells-derived mitoplasts. Traces are a representative single recording of IMCU. n = 7–8.
(F) Average IMCU densities at 5 mM Ca
2+ in control and CVD ECs. Mean ± SEM; *p < 0.05; n = 7–8.
(G and H) Representative images and quantitation of MitoSOX Red fluorescence (mROS indicator) in control, CVD, and CVD +MICU1 rescue ECs. Mean ± SEM;
***p < 0.001; n = 3–12.
(I and J) Representative images and quantitation of migratory scratch assay in CVD and CVD + MICU1 rescue ECs. Mean ± SEM; *p < 0.05, **p < 0.01; n = 3–5.higher current density (Figures 6E and 6F) suggesting that the
increased Ca2+ uptake is a result of increased open probability
of MCU due to lower expression of MICU1 (Figures 6A and
6D). Aberrant basal mitochondrial Ca2+ uptake may lead to mito-
chondrial oxidative stress in the form of superoxide, which is
produced when electrons leak from the electron transport chain
to react with molecular oxygen. Ablation of MICU1 in the EC cell
line, EA.hy926, increased mitochondrial superoxide levels (Fig-
ures S4C–S4E). In CVD ECs, loss of MICU1 resulted in higher
[Ca2+]m, through altered MCU-mediated mitochondrial Ca
2+
uptake which subsequently increased basal superoxide levels
(Figures 6G and 6H). We next tested whether elevated reactive
oxygen species (ROS) from MICU1 knockdown lowers antioxi-1584 Cell Reports 5, 1576–1588, December 26, 2013 ª2013 The Autdant levels and alters EC proliferation (Balaban et al., 2005).
Total reduced glutathione (GSH) content was assessed in
EA.hy926 ECs expressing MICU1 shRNA or MICU1 shRNA +
shRNA-insensitive MICU1. Reconstitution of MICU1 in MICU1
KD cells prevented the chronic ROS-induced reduction of
GSH levels (Figures S4F and S4G). Further, reduced cell prolif-
eration in MICU1-silenced ECs was restored by reconstitution
with shRNA-insensitive MICU1cDNA (Figures S4H and S4I).
Another key functional question is whether loss of MICU1 leads
to altered angiogenesis in CVD. CVD-derived ECs exhibited
diminished migration, which was rescued by stable expression
of MICU1 (Figures 6I and 6J). We next tested whether CVD-
derived ECs have an altered monocyte adhesion phenotype.hors
Figure 7. In Vivo Knockdown of MICU1 Pro-
motes Endothelial [Ca2+]m Accumulation,
ROS Elevation, and Vascular Integrity Loss
(A) Knockdown of MICU1 mRNA levels in mouse
endothelial cells after MICU1 shRNA lentiviral
delivery. Total mRNA was isolated from ECs, and
qRT-PCR was performed. Mean ± SEM; ***p <
0.001, n = 5.
(B) Quantitation of basal [Ca2+]m accumulation in
control and MICU1KD mouse ECs (left panel).
Quantitation of basal ROS levels in control and
MICU1KD mouse ECs (right panel). Mean ± SEM;
*p < 0.05, ***p < 0.001; n = 5.
(C) A 0.1–0.15 ml bolus of fluorescein isothiocya-
nate (FITC)-dextran (70 kDa, 5%w/v) was injected
into the animals via facial vein. Anesthetized ani-
mals were placed under an intravital two-photon
imaging system (Zeiss 710 META NLO), and
images were acquired. Images are representative
of multiple independent experiments. n = 5.
(D) Quantitation of vascular leakage was assessed
as extravascular FITC-dextran fluorescence
intensity. Mean ± SEM; **p < 0.01; n = 5.We observed that CVD-derived ECs have an inherent propensity
for monocyte adhesion (Figures S4J and S4K).
To explore the human MICU1 phenotype, we silenced MICU1
in mice and investigated the mitochondrial Ca2+ handling and
vascular integrity. In vivo lentiviral delivery of MICU1 shRNA
effectively knockeddownMICU1mRNA levels in ECs (Figure 7A).
We also tested the MICU1 mRNA levels in cardiomyocytes,
smooth muscle cells (SMCs), and splenocytes. Although SMCs
and splenocytes, but not cardiomyocytes, showed partial
knockdown of MICU1 following shRNA delivery, the MICU1
knockdown is more pronounced in ECs (Figure S5). Similar to
cell-based and CVD-derived studies, downregulation of MICU1
expression promoted higher basal [Ca2+]m and ROS production
(Figure 7B) culminating as a loss of vascular integrity (Figures 7C
and 7D). Collectively, these results show that loss of MICU1
leads to aberrant EC mitochondrial Ca2+ handling and vascular
pathology.
DISCUSSION
These findings establish that mitochondrial matrix resident,
MICU1, forms regulatory oligomers that require the MICU1 poly-
basic region forMCUbinding and suppression of IMCU. However,
the polybasic region of MICU1 does not determine MICU1 olig-
omerization. Additionally, MICU1 EF hands which confer func-
tional regulation of IMCU do not determine MICU1/MCU complex
formation. Our experiments also establish that the coiled-coil
domains of MCU are essential for MICU1 binding.
Identifying the physiological function of protein regions re-
mains a challenge for advanced bioinformatics and requiresCell Reports 5, 1576–1588, Debroad-based biochemical techniques.
One such technique, the protein dynamic
flux assay, provided a tool to discover
MICU1 protein localization in the mito-
chondria while circumventing currentconventionalmicroscopy resolution limits. Themajor advantages
of this method are that it is rapid, specific, real-time imaging,
without RNAi silencing, subcellular fractionation, or antibodies,
and it can resolve compartmentalization-determined protein
functions such as residues of MCU accessible to MICU1. Taking
the next step from localization, we show that the N-terminal re-
gionof theMICU1polybasicmotif determinesMICU1/MCUbind-
ing.Whereas the polybasicmotif has been previously reported to
enhance protein-protein interaction (Williams, 2003), the polyba-
sic motif is now identified in the mitochondria. The dominant
negative MICU1-DK oligomer phenotype is likely a result of
MICU1-DK interactingwithwild-typeMICU1, either sequestering
wild-type MICU1 or causing a reduction of MICU1 oligomeric
complex-binding affinity for MCU. Together, these data suggest
that the polybasic region of MICU1 is not a MICU1/MICU1 inter-
action domain but supports the polybasic region’s role in MCU
interaction. The loss of MICU1 regulation by polybasic mutation
could also be explained by diminished interaction of the polyba-
sic mutant with the inner leaflet of the IMM. In support of this, the
conserved polybasic region contains a glycine residue that could
undergo myristoylation for membrane anchoring (Mumby et al.,
1990; Thelen et al., 1991). This anchor could provide a mecha-
nism for MICU1 to come on and off at active and resting state.
This loose association is supported by our FRAP studies which
show that MICU1 as a population is more mobile than MCU (Fig-
ure 1R). Thesecritically important anddiverse roles of the polyba-
sic region and its role inmitochondrial Ca2+ signalingwill certainly
be elucidated in future studies.
Despite physiological mitochondrial Ca2+ uptake partici-
pates in mitochondrial bioenergetics and cellular Ca2+ signaling,cember 26, 2013 ª2013 The Authors 1585
chronic Ca2+ accumulation is known to elicit mitochondrial
dysfunction through mitochondrial permeability transition pore
opening, mitochondrial ROS elevation, and cell death (Duchen
et al., 2008; Hajno´czky et al., 2006). The mitochondrial Ca2+-
dependent cellular damage pathways are shared in many path-
ophysiological models, like cardiovascular disease, aging, and
neurodegeneration (Davidson and Duchen, 2007). In cardiovas-
cular diseases, the endothelium suffers from Ca2+-dependent
damage (Davidson and Duchen, 2007). Our results establish
that endothelial cells derived from CVD subjects show low levels
of MICU1 (Figures 6 and 7) and that the mitochondrial Ca2+-
uptake component of the disease phenotype can be reversed
by the reconstitution of MICU1, thus restoring endothelial cell
migration.
Collectively, we established a unique resolution-independent
confocal technique to characterize the localization of com-
plex components in viable organelles. Most importantly, we
revealed that MICU1 interacts with MCU and regulates MCU-
dependent [Ca2+]m uptake with a polybasic region and Ca
2+-
sensing EF hand motifs. Additionally, we have shown that
the coiled-coil domains of MCU interact with MICU1. Identifica-
tion of these MICU1 and MCU domains provide the critical
targets for mitochondrial Ca2+ uptake and potential therapeutic
intervention in the pathogenesis of cardiovascular disease
states.EXPERIMENTAL PROCEDURES
Dynamic Protein Flux Assay
For all studies, MICU1, MCU, and other plasmid constructs were generated
from human sequences. HeLa cells were cotransfected with cyto c-GFP
and COX8A-mRFP (mitochondrial targeting sequence [MTS]), MICU1-YFP
and COX8-mRFP, or MCU-GFP and COX8-mRFP plasmid constructs.
Forty-eight hours posttransfection, cells were permeabilized with digitonin
(0.002% w/v) for 7 min. Permeabilized cells were washed with digitonin-free
intracellular-like medium supplemented with 2 mM succinate. After 100 s of
baseline recording, permeabilized cells were exposed to either mastoparan
(20 mg/ml) or alamethicin (20 mg/ml) at the indicated time points. Confocal
images were recorded every 10 s (510 Meta; Carl Zeiss) at 488 and 561 nm
excitation using a 403 oil objective. Experiments were performed under
pinhole settings of approximately 2.3 mm to mitigate the impact of MICU1
rearrangement within the mitochondria. After completion of the time series,
protein distribution maps were generated for before and after the mitochon-
drial membrane-permeabilizing agents. Images were analyzed, and flux rate
was calculated. The colored histogram depiction represents the distribution
of resolvable bit fluorescent intensities. Time is plotted from initial (top) to final
(bottom) using the same individual experiment depicted in the representative
individual trace. The intervals (bars) represent different time(s) during which
the experiment was performed with the top bar indicating before the addition
of either mastoparan or alamethicin. The protein flux images were analyzed
using Zen 2010 software.FRAP Analysis
HeLa cells transfected with either MCU-GFP or MICU1-YFP were grown on
glass coverslips for 48 hr before FRAP experiments. After baseline images
were captured (one image/s), a small region (approximately 5% cytoplasmic
area) was bleached with ten iterations of 488 nm at 100% laser power using
a Zeiss 510 confocal microscope. Recordings of fluorescence recovery
were captured for the following 45 s at 488 nm excitation. Recovery in the
bleached region was the sum of all diffusing molecules, and normalized inten-
sity was calculated as a percentage of the difference between the initial and
bleached fluorescent arbitrary unit value.1586 Cell Reports 5, 1576–1588, December 26, 2013 ª2013 The AutMeasurement of Mitochondrial Ca2+ Uptake and Mitochondrial
Membrane Potential in Permeabilized Cell System
Control, MICU1-DEF1DEF2, or MICU1-DK mutant HeLa cells were permeabi-
lized using intracellular-likemediumcontaining 2 mMthapsigargin and 40 mg/ml
digitonin. The cell suspension supplementedwith succinate (5mM)was placed
in a fluorimeter and permeabilized by gentle stirring. Fura-2FF (0.5 mM) was
added at 0 s and JC-1 (800 nM) at 20 s to simultaneously measure extra-
mitochondrial Ca2+ and DJm, respectively. Fluorescence was monitored in a
temperature-controlled (37C) multiwavelength-excitation dual wavelength-
emission spectrofluorometer (Delta RAM, Photon Technology International)
using 490 nm excitation/535 nm emission for the monomer, 570 nm excita-
tion/595 nm emission for the J-aggregate of JC-1, and 340 nm/380 nm for
Fura-2FF. The ratiometric dye, Fura-2FF, was calibrated as previously
described (Mallilankaraman et al., 2012b). At 450 s, 1mMCa2+pulsewas added
and DJm and extramitochondrial Ca
2+ were monitored simultaneously. CCCP
was added at 750 s to determine mitochondrial Ca2+ content.
Mitoplast Patch-Clamp Recording
Mitoplast patch-clamp recordings were performed at 30C as detailed previ-
ously with modifications (Kirichok et al., 2004). Currents were recorded using
a computer-controlled Axon200B patch-clamp amplifier with a Digidata 1320A
acquisition board (pClamp 10.0 software; Axon Instruments). The ionic
composition of the pipette (2, 5, and 100 mMCa2+) was chosen based on pre-
vious measurements. Mitoplasts with p-orbital morphology were used for
patch-clamp recording. Mitoplasts were bathed with a solution containing
sodium gluconate (150 mM), KCl (5.4 mM), CaCl2 (5 mM), HEPES (10 mM),
with a pH of 7.2. The pipette solution contained sodium gluconate (150 mM),
NaCl (5 mM), sucrose (135 mM), HEPES (10 mM), and EGTA (1.5 mM), with
a pH of 7.2. After formation of GU seals (pipette resistance 20–35 MU), the
mitoplasts were ruptured with 200–400 mV pulse varying from 2 to 6 ms dura-
tion. Mitoplast capacitance was measured (2.2–3.8 pF). After capacitance
compensation, mitoplasts were held at 0 mV and IMCU were elicited with a
voltage ramp (from 160 mV to 80 mV, 120 mV/s).
Isolation of Endothelial Cells from CVD and Control Subjects
Primary ECs were isolated from arteries and veins obtained from individuals
undergoing surgical intervention for coronary artery disease (CAD)/peripheral
artery disease (PAD) at the surgical unit of Temple University Hospital after due
ethical clearance. The tissueswere collected in standard EC transport medium
and transported to the laboratory through cold chain and processed immedi-
ately. The tissues were initially washed once with PBS containing 100 U/ml
penicillin and 100 mg/ml streptomycin and then cleaned to remove the fibrous
portion with sterile forceps. Using a sterile blade, the veins were cut vertically
and carefully flipped over. The tissues were cut into small squares of approx-
imately 0.5 cm3 0.5 cm and placed in a 100mmdish with medium just bathing
the tissue pieces. The plates were incubated at 37C, 5% CO2. After 1 week,
the tissue pieces were removed leaving the individual colonies to develop into
a confluent monolayer. Endothelial cell phenotypes were characterized as
previously described (Milovanova et al., 2008).
Endothelial Migration Assay
Control, CVD-derived ECs, and CVD + MICU1 rescue ECs were seeded at a
density of 13 105 cells/well in 6-well plates overnight for confluent monolayer.
A uniform 1.8 mm scratch running the entire length of the well was created
using a sterile 200 ml tip. The wells were washed three times with PBS to
remove the cell debris and then bathed in 2 ml complete endothelial medium.
After 24 hr, cells were washed and fixed with CAMCO Quick Stain II as per
manufacturer instructions. The wells were photographed at multiple locations
using phase contrast microscopy with a 43 objective. Migration was quanti-
fied using Image J software (National Institutes of Health); results are ex-
pressed as percent gap closure (Craige et al., 2011).
In Vivo Knockdown of MICU1 and Vascular Integrity Measurement
To knock down MICU1 in control mice, we used lentivirus carrying MICU1-
shRNA. Three daily doses of MICU1-shNRA (1 3 108 TU/ml as measured by
p24 ELISA and also confirmed by true infectious titer via puromycin resistance
in EC culture; 100 ml/mice was delivered using saline as vehicle) lentivirus orhors
control lentivirus-negative shRNA were administered intravenously, and
MICU1 expression in the endothelial cells, cardiomyocytes, SMCs, and sple-
nocytes were assessed by qRT-PCR after 5 days from the last injection (8 total
days). Freshly isolated primary ECs were rapidly subjected to [Ca2+]m and ROS
measurement. The vascular integrity studies were performed as described
previously (Gandhirajan et al., 2013).
Statistical Analysis
Data were expressed as the means ± SE. Statistical significance was evalu-
ated via one-way ANOVA and Student’s t test. A p value of <0.05 was consid-
ered statistically significant. All experiments were conducted at least three
times unless specified. Data were plotted either with GraphPad Prism version
5.0 or with Sigma Plot 11.0 software.
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